Engineering monoclonal antibody-based contraception and multipurpose prevention technologies† is a research paper published in Biology of Reproduction (2020). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R61HD099747
National Institutes of Health
Grant: R44HD097063 506
National Institutes of Health
Grant: R43HD094454
National Institutes of Health
Grant: R01HD095630
National Institutes of Health
Grant: P50HD096957
National Institutes of Health
Grant: 5R61HD099747-02
Nonhormonal contraceptive intravaginal ring based on high valency anti-sperm antibody constructs
National Institutes of Health
Grant: 5R61HD099745-02
Synthetic mRNA-mediated reversible immunocontraception
National Institutes of Health
Grant: 5R44HD097063-03
Capsule-intravaginal ring for sustained release of antibodies for non-hormonal contraception and vaginal protection against HIV
National Institutes of Health
Grant: 5R01HD095630-03
Project Three: Assessing effects of anti-CD52g Mabs on STD pathogens in semen
National Institutes of Health
Grant: 1R43HD094454-01A1
Development of a biologic for non-hormonal contraception
National Institutes of Health
Grant: 5P50HD096957-02
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research
Fields of Study
Keywords
Sustainable Development Goals